Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Drew Trainor

Physical Medicine & Rehabilitation Greenwood Village, CO Medical Doctor

NPI 1013279884 CMS profile 1189225

7730 E Belleveiw Ave, Suite A-104, Greenwood Village, CO 80111

Open in the dashboard

General payments

$320,279

600 records reported · program years 2019–2025

Research payments

$9,660

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,478,576 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Drew Trainor of Greenwood Village, CO is reported in the CMS Open Payments database as having received $320,279 across 600 general payments and $9,660 in research payments paid to them. Separately, studies naming them as principal investigator received $1,478,576 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Physical Medicine & Rehabilitation profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $81,162 119
2024 General $65,657 132
2023 General $49,723 93
2022 General $51,847 124
2021 General $48,759 69
2021 Research $9,660 2
2020 General $19,180 30
2019 General $3,950 33

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Drew Trainor
  • Physical Medicine & Rehabilitation median
  • Middle half of Physical Medicine & Rehabilitation
  • National median

In program year 2025, general payments to Drew Trainor were reported at $81,162. Among 4,146 Physical Medicine & Rehabilitation profiles paid that year, the median was $139 and the middle half received between $48 and $410.

Show as a table
Year Drew Trainor Physical Medicine & Rehabilitation median Middle half National median
2019 $3,950 $133 $45–$390 $163
2020 $19,180 $88 $29–$272 $114
2021 $48,759 $116 $33–$360 $132
2022 $51,847 $123 $40–$378 $149
2023 $49,723 $131 $43–$396 $160
2024 $65,657 $141 $45–$409 $164
2025 $81,162 $139 $48–$410 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $235,754 379 payments
  2. Saluda Medical Americas, Inc. $56,059 67 payments
  3. Vertos Medical, Inc. $8,793 18 payments
  4. Nalu Medical, Inc. $7,114 13 payments
  5. Stryker Corporation $4,153 3 payments
  6. Nevro Corp. $2,413 24 payments
  7. Vertiflex, Inc. $1,342 8 payments
  8. SPR Therapeutics, Inc $1,329 12 payments
  9. Painteq LLC $1,243 21 payments
  10. Abbott Laboratories $774 13 payments
  11. Other $1,305 42 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $173,403 99 payments
  2. Consulting Fee $90,750 42 payments
  3. Travel and Lodging $35,357 136 payments
  4. Food and Beverage $20,769 323 payments
Products named General payments · program years 2019–2025
  1. General - Therapies $57,051 73 payments
  2. Evoke $55,871 65 payments
  3. WaveWriter Alpha Prime 16 $25,966 59 payments
  4. WAVEWRITER ALPHA $15,153 11 payments
  5. SPECTRA WAVEWRITER Pain Management $14,454 17 payments
  6. GENERAL PAIN MANAGEMENT $14,177 13 payments
  7. SPECTRA WAVEWRITER Pain Management $9,916 24 payments
  8. mild Device Kit $8,793 18 payments
  9. Nalu Neurostimulation System $7,114 13 payments
  10. GENERAL - PAIN MANAGEMENT $4,541 8 payments
  11. Other $22,033 175 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Boston Scientific Corporation $9,660 2 payments

Prescribing to Medicare patients

Part D · data year 2024 · 21 drugs

Part D claims

668

Median for Physical Medicine and Rehabilitation: 276

Drug cost

$28,368

Median for Physical Medicine and Rehabilitation: $5,921

Branded share of claims

19.3%

Median for Physical Medicine and Rehabilitation: 11.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Buprenorphine Generic 40 $11,822
Lidocaine Generic 19 $3,207
Gabapentin Generic 111 $2,439
Oxycodone Hcl Generic 80 $1,864
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 53 $1,517
Fentanyl Generic 14 $1,303
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 39 $1,126
Tramadol Hcl Er Tramadol Hcl Brand 17 $865
Morphine Sulfate Er Morphine Sulfate Brand 20 $732
Duloxetine Hcl Generic 31 $582

The 10 drugs with the highest cost, of 21 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 70 billing codes

Paid by Medicare

$138,664

Of which drugs: $8,334

Medicare patients

337

Average age 74

Services billed

3,784

191 women, 146 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 66%
Depression 33%
Ischemic heart disease 24%
Osteoporosis 24%
Diabetes 18%
Chronic kidney disease 16%
Atrial fibrillation 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 11 800 $82
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 15 96 $71

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BOTOX
  • AbbVie, Inc. $28
$28 — —
RELISTOR
  • Salix Pharmaceuticals, a division of Bausch Health US, LLC $21
$21 — —
QULIPTA
  • AbbVie, Inc. $20
$20 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

602 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physical Medicine & Rehabilitation in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record